In vivo, in conscious swine a model with GH axis pharmacology closely reflective of human GH secretion ipamorelin produced an ED50 of 2.3 0.03 nmol/kg and an Emax of 65 0.2 ng GH/mL plasma, comparable to GHRP-6 (ED50 3.9 1.4 nmol/kg, Emax 74 7 ng/mL) but with substantially superior selectivity
IGF-I stimulates myoblast proliferation and differentiation, and is implicated in the regulation of muscle growth [6, 7]
Although curcumin functions as an iron-chelating agent, its effects on ferroptosis are conflicting and still under investigation
Safety Considerations and Future Outlook As with all pharmacotherapy for obesity and T2D, establishing cardiovascular safety and demonstrating improvements in meaningful clinical outcomes will be essential, particularly as cardiovascular outcome trials have not yet been completed with multi-agonists (although data are expected soon for tirzepatide: SURPASS-CVOT [T2D] in 2025
Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors
DSIPs benefits appear to stem from its ability to optimize natural physiological processes rather than forcing specific outcomes